Axogen (AXGN) Net Cash Flow Growth (3y) (2013 - 2026)
Axogen (AXGN) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | -48.90% |
| 10 | Axogen | 2.10 Bn | 1.99 Bn | 46.19 Mn | 99.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.61% |
| Dec 31, 2025 | 129.30% |
| Sep 30, 2025 | -9.25% |
| Jun 30, 2025 | 39.39% |
| Mar 31, 2025 | 19.60% |
| Dec 31, 2024 | 38.08% |
| Sep 30, 2024 | 56.38% |
| Jun 30, 2024 | -35.96% |
| Mar 31, 2024 | -17.53% |
| Dec 31, 2023 | 82.00% |
| Sep 30, 2023 | 34.19% |
| Jun 30, 2023 | -29.38% |
| Mar 31, 2023 | -259.77% |
| Dec 31, 2022 | -55.78% |
| Sep 30, 2022 | 113.49% |
| Jun 30, 2022 | -58.99% |
| Mar 31, 2022 | -186.72% |
| Dec 31, 2021 | -71.15% |
| Sep 30, 2021 | 61.11% |
| Jun 30, 2021 | -49.54% |